Diabetes Management Devices Market : Latest Research Reveals Key Trends for Business Growth| Medtronic plc, F.Hoffmann-La-Roche Ltd., Abbott Laboratories Inc., Johnson & Johnson, Novo Nordisk A/S, Bayer AG, Insulet Corp., Sanofi SA

Global Diabetes Management Market Analysis and Forecast 2019-2028

Market Introduction

The global diabetes management market is expected to witness a strong growth rate of 8.4% during the forecast period of 2022-2028. The growth of the global diabetes management market is attributed to the rising incidence of diabetes among the younger as well as the geriatric population. Moreover, disease like obesity and the prevalence of junk food and alcohol among the younger population is expected to escalate the number of diabetic patients across the globe, which in turn will fuel the growth of the diabetes management market. In addition, the continuous R&D in the healthcare sector along with the introduction of innovative devices gives a thrust to the global diabetes management devices. Moreover, the higher incidences of diabetes (Type I & Type II) in the geriatric population across the globe are high which is increasing the demand for devices such as insulin pens and pumps and hence drives the growth of the diabetes management devices market.

Request Sample Copy @ https://www.themarketinsights.com/request-sample/265147

Market Segmentation

The global diabetes management market is segmented on the basis of device type, end-user, distribution channel, and region. Based on device type, the market is divided into blood glucose monitoring devices and insulin delivery devices. Further, blood glucose monitoring device is divided into, self-monitoring devices and continuous glucose monitoring devices, and continuous glucose monitoring device are segmented into insulin pens, insulin pumps, insulin syringes, and others including jet injectors. On the basis of end-user, the market is segmented into diagnostics centers, hospitals, and home care. Based on the distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, diabetes centres/clinics, and E-commerce websites. Based on region, the market is divided into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, and Middle East & Africa. Further, North America is divided into US and Canada. Latin America is further segmented on the basis of Brazil, Mexico, and the Rest of Latin America. Western Europe is further segmented into Germany, the UK, France, Spain, Italy, Benelux, Nordic, and the rest of western Europe. Eastern Europe is segmented into Russia, Poland, and the rest of Eastern Europe. Based on the Asia Pacific, the market is further segmented into China, India, Japan, South Korea, Australia, ASEAN (Indonesia, Vietnam, Malaysia, etc.) countries, and the rest of Asia Pacific. Lastly, on the basis of the Middle East & Africa market is segmented into GCC Countries, South Africa, Turkey, and the rest of the Middle East & Africa.

Check for Discount @ https://www.themarketinsights.com/check-discount/265147

Market structure and competitive landscape
The global diabetes management market is fragmented in nature, some of the prominent players that contribute significantly to the global enterprise resource planning market include, Medtronic plc,
F.Hoffmann-La-Roche Ltd.,
Abbott Laboratories Inc.,
Johnson & Johnson,
Novo Nordisk A/S,
Bayer AG,
Insulet Corp.,
Sanofi SA,
Lifescan Inc.,
B Braun Melsungen AG,
Rossmax International Ltd.,
Eli Lilly and Company,
and Ypsomed Holdings
are some of the key players operating in the market.
Product Launches, Mergers & Acquisitions, joint ventures, and R&D activities are key strategies adopted by the players in the global diabetes management market. These companies adopt numerous approaches to strengthen their market share and gain a competitive edge over other competitors in the market. Some of the key developments in the North America Cooking Robots market include,
In May 2021, Eli Lily and Company collaborated with DexCom, Inc., Glooko Inc., myDiabby Healthcare, and Roche with a goal to integrate data and technology to help streamline diabetes management.
In November 2020, a Denmark-based bio-medical device manufacturer Novo Nordisk A/S acquired the 100% share of Emisphere Technologies.
In April 2020, a Switzerland-based company Ypsomed partnered with the US-based company DexCom, Inc. for the integration of DexCom s G6 sensors with its mylife YpsoPump data to produce a hybrid system.

Report Customization available as per requirements @ https://www.themarketinsights.com/request-customization/265147

Table of Content

Chapter One: Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation
Chapter Two: Assumptions and Acronyms
Chapter Three: Executive Summary
3.1. Global Market in2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
Chapter Four: Research Methodology
Chapter Five: Analysis of COVID-19 Impact and Road Ahead
5.1. Impact on Growth Strategies
5.2. Impact on Operations and Supply Chain
5.3. Impact on Product Roll-outs Plans
Chapter Six: Market Indicators and Background
6.1. Macro-Economic Factors
6.1.1. Global Population Overview and Forecast
6.1.2. Rising Prevalence of Diabetes
6.1.3. Increasing Incidences of Obesity
6.1.4. Increasing Geriatric Population
6.1.5. Healthcare Expenditure by Selected Countries/Region
6.2. Forecasting Factors
Robust assessment of various factors including industrial performance, industry players expenditures, and economic conditions, among others
6.3. Supply Chain & Value Chain Analysis
6.3.1. Raw Material Suppliers
6.3.2. Diabetes Management Devices Manufacturers
6.3.3. Key End Users
6.3.4. Marketing Channel
6.3.4.1. Direct Marketing
6.3.4.2. Indirect Marketing
6.3.4.3. Marketing Channel Development Trend
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter s Five Forces Analysis
Chapter Seven: Government Laws and Industry Regulations
Chapter Eight: Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities
Chapter Nine: Global Diabetes Management Devices Market: Key Investment Analysis
9.1. By Manufacturers
9.2. By Region
9.3. M&A Activities
Robust assessment of major investments made by various industry players along with key application areas, technological assessment, and key end-use sector
Chapter Ten: Pricing Analysis
10.1. By Leading Organizations
10.2. By Type
10.3. By Region
10.3.1. North America
10.3.2. Western Europe
10.3.3. Eastern Europe
10.3.4. Asia Pacific
10.3.5. Latin America
10.3.6. Middle East & Africa
Chapter Eleven: Parent Market Overview: Global Medical Devices Market
Chapter Twelve: Segmental Analysis
12.1. Global Diabetes Management Devices Market by Device Type
12.1.1. Segment Overview
12.1.1.1. Blood Glucose Monitoring Device
12.1.1.1.1. Self-Monitoring Devices
12.1.1.1.2. Continuous Glucose Monitoring Device
12.1.1.2. Insulin Delivery Device
12.1.1.2.1. Insulin Pens
12.1.1.2.2. Insulin Pumps
12.1.1.2.3. Insulin Syringes
12.1.1.2.4. Others (Jet Injectors)
12.2. Global Diabetes Management Devices Market by End User
12.2.1. Segment Overview
12.2.1.1. Hospitals
12.2.1.2. Homecare
12.2.1.3. Diagnostics Centre
12.3. Global Diabetes Management Devices Market by Distribution Channel
12.3.1. Segment Overview
12.3.1.1. Retail Pharmacies
12.3.1.2. Hospital Pharmacies
12.3.1.3. Diabetes Centers/ Clinics
12.3.1.4. E-commerce Websites
12.4. Global Diabetes Management Devices Market by Region
12.4.1. North America
12.4.2. Latin America
12.4.3. Western Europe
12.4.4. Eastern Europe
12.4.5. Asia Pacific
12.4.6. Middle East & Africa
Chapter Thirteen: Regional Analysis
13.1. North America Diabetes Management Devices Market Analysis and Forecast2019-2028
13.1.1. Regional Market Overview and Key Takeaways
13.1.2. North America Diabetes Management Devices Market by Device Type
13.1.3. North America Diabetes Management Devices Market by End User
13.1.4. North America Diabetes Management Devices Market by Distribution Channel
13.1.5. North America Diabetes Management Devices Market by Country
13.1.5.1. US
13.1.5.2. Canada
13.2. Latin America Diabetes Management Devices Market Analysis and Forecast2019-2028
13.2.1. Regional Market Overview and Key Takeaways
13.2.2. Latin America Diabetes Management Devices Market by Device Type
13.2.3. Latin America Diabetes Management Devices Market by End User
13.2.4. Latin America Diabetes Management Devices Market by Distribution Channel
13.2.5. Latin America Diabetes Management Devices Market by Country
13.2.5.1. Brazil
13.2.5.2. Mexico
13.2.5.3. Rest of Latin America
13.3. Western Europe Diabetes Management Devices Market Analysis and Forecast2019-2028
13.3.1. Regional Market Overview and Key Takeaways
13.3.2. Western EuropeDiabetes Management Devices Market by Device Type
13.3.3. Western EuropeDiabetes Management Devices Market by End User
13.3.4. Western Europe Diabetes Management Devices Market by Distribution Channel
13.3.5. Western EuropeDiabetes Management Devices Market by Country
13.3.5.1. Germany
13.3.5.2. UK
13.3.5.3. France
13.3.5.4. Spain
13.3.5.5. Italy
13.3.5.6. Benelux
13.3.5.7. Nordic
13.3.5.8. Rest of Western Europe
13.4. Eastern Europe Diabetes Management Devices Market Analysis and Forecast2019-2028
13.4.1. Regional Market Overview and Key Takeaways
13.4.2. Eastern Europe Diabetes Management Devices Market by Device Type
13.4.3. Eastern Europe Diabetes Management Devices Market by End User
13.4.4. Eastern Europe Diabetes Management Devices Market by Distribution Channel
13.4.5. Eastern Europe Diabetes Management Devices Market by Country
13.4.5.1. Russia
13.4.5.2. Poland
13.4.5.3. Rest of Eastern Europe
13.5. Asia Pacific Diabetes Management Devices Market Analysis and Forecast2019-2028
13.5.1. Regional Market Overview and Key Takeaways
13.5.2. Asia Pacific Diabetes Management Devices Market by Device Type
13.5.3. Asia Pacific Diabetes Management Devices Market by End User
13.5.4. Asia Pacific Diabetes Management Devices Market by Distribution Channel
13.5.5. Asia Pacific Diabetes Management Devices Market by Country
13.5.5.1. China
13.5.5.2. Japan
13.5.5.3. India
13.5.5.4. South Korea
13.5.5.5. Australia
13.5.5.6. ASEAN
13.5.5.7. Rest of Asia-Pacific
13.6. Middle East & Africa Diabetes Management Devices Market Analysis and Forecast2019-2028
13.6.1. Regional Market Overview and Key Takeaways
13.6.2. Middle East & Africa Diabetes Management Devices Market by Device Type
13.6.3. Middle East & Africa Diabetes Management Devices Market by End User
13.6.4. Middle East & Africa Diabetes Management Devices Market by Distribution Channel
13.6.5. Middle East & Africa Diabetes Management Devices Market by Country
13.6.5.1. GCC
13.6.5.2. South Africa
13.6.5.3. Turkey
13.6.5.4. Rest of the Middle East & Africa
Chapter Fourteen: Competitive Landscape
14.1. Competition Dashboard
14.1.1. Global and Regional Market Share Analysis
14.1.2. Market Structure
14.2. Competitive Benchmarking
14.3. Key Strategy Analysis
14.4. Company Profiles
14.4.1. Medtronic plc
14.4.1.1. Company Overview
14.4.1.2. Product/Service Offerings
14.4.1.3. Key Financials
14.4.1.4. Recent Developments
14.4.2. F. Hoffmann-La-Roche Ltd.
14.4.2.1. Company Overview
14.4.2.2. Product/Service Offerings
14.4.2.3. Financials
14.4.2.4. Recent Developments
14.4.3. Abbott Laboratories Inc.
14.4.3.1. Company Overview
14.4.3.2. Product/Service Offerings
14.4.3.3. Financials
14.4.3.4. Recent Developments
14.4.4. Johnson & Johnson
14.4.4.1. Company Overview
14.4.4.2. Product/Service Offerings
14.4.4.3. Financials
14.4.4.4. Recent Developments
14.4.5. Novo Nordisk A/S
14.4.5.1. Company Overview
14.4.5.2. Product/Service Offerings
14.4.5.3. Financials
14.4.5.4. Recent Developments
14.4.6. Bayer AG
14.4.6.1. Company Overview
14.4.6.2. Product/Service Offerings
14.4.6.3. Financials
14.4.6.4. Recent Developments
14.4.7. Insulet Corp.
14.4.7.1. Company Overview
14.4.7.2. Product/Service Offerings
14.4.7.3. Financials
14.4.7.4. Recent Developments
14.4.8. Sanofi SA
14.4.8.1. Company Overview
14.4.8.2. Product/Service Offerings
14.4.8.3. Financials
14.4.8.4. Recent Developments
14.4.9. Lifescan Inc.
14.4.9.1. Company Overview
14.4.9.2. Product/Service Offerings
14.4.9.3. Financials
14.4.9.4. Recent Developments
14.4.10. B Braun Melsungen AG
14.4.10.1. Company Overview
14.4.10.2. Product/Service Offerings
14.4.10.3. Financials
14.4.10.4. Recent Developments
14.4.11. Rossmax International Ltd.
14.4.11.1. Company Overview
14.4.11.2. Product/Service Offerings
14.4.11.3. Financials
14.4.11.4. Recent Developments
14.4.12. Eli Lilly and Company
14.4.12.1. Company Overview
14.4.12.2. Product/Service Offerings
14.4.12.3. Financials
14.4.12.4. Recent Developments
14.4.13. Ypsomed Holdings
14.4.13.1. Company Overview
14.4.13.2. Product/Service Offerings
14.4.13.3. Financials
14.4.13.4. Recent Developments
A comprehensive list of diabetes management devices manufacturers will be provided along with geographical reach, employee count, revenue, product capacities, and their capabilities
Chapter Fifteen: Disclaimer

Direct Contact
Jessica Joyal
+1(213)338-8279 | +1(877)376-9989
sales@themarketinsights.com

About us.
Delivering foresights along with statistical analysis of the operational business industry impacts has been our foremost priority. With the constant developments in the research & development industry, we have always challenged the conventional research methodologies and discovered new research tactics to evolve the growing B2B requirements.

This release was published on openPR.